Research Article

You have full text access to this OnlineOpen article

Differential recognition of heat-shock protein dnaJ–derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis

  1. Margherita Massa1,
  2. Maristella Passalia1,
  3. Silvia Magni Manzoni2,
  4. Rita Campanelli1,
  5. Laura Ciardelli2,
  6. Gisella Puga Yung3,
  7. Sylvia Kamphuis4,
  8. Angela Pistorio5,
  9. Valentina Meli6,
  10. Alessandro Sette7,
  11. Berent Prakken4,†,
  12. Alberto Martini8,
  13. Salvatore Albani9,†,*

Article first published online: 27 APR 2007

DOI: 10.1002/art.22567

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 56, Issue 5, pages 1648–1657, May 2007

Additional Information

How to Cite

Massa, M., Passalia, M., Manzoni, S. M., Campanelli, R., Ciardelli, L., Yung, G. P., Kamphuis, S., Pistorio, A., Meli, V., Sette, A., Prakken, B., Martini, A. and Albani, S. (2007), Differential recognition of heat-shock protein dnaJ–derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. Arthritis & Rheumatism, 56: 1648–1657. doi: 10.1002/art.22567

Author Information

  1. 1

    Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  2. 2

    Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  3. 3

    University of California, San Diego, La Jolla, California, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  4. 4

    University Medical Center Utrecht, Utrecht, The Netherlands, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  5. 5

    IRCCS G. Gaslini, Genoa, Italy

  6. 6

    Androclus Therapeutics, Milan, Italy, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  7. 7

    La Jolla Institute for Allergy and Immunology, La Jolla, California

  8. 8

    IRCCS G. Gaslini, University of Genoa, Genoa, Italy, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  9. 9

    University of California, San Diego, La Jolla, California, Androclus Therapeutics, Milan, Italy, and EUREKA Institute for Translational Medicine, Siracusa, Italy

  1. †

    Drs. Prakken and Albani are coinventors of concepts and sequences, patents for which are owned by University of California, San Diego.

*University of California at San Diego, Departments of Medicine and Pediatrics, 9500 Gilman Drive, La Jolla, CA 92093-0731

Publication History

  1. Issue published online: 27 APR 2007
  2. Article first published online: 27 APR 2007
  3. Manuscript Accepted: 24 JAN 2007
  4. Manuscript Received: 20 DEC 2005

Funded by

  • “Ricerca Corrente” grants from the IRCCS Policlinico San Matteo, Pavia, Italy

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (217K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Salvatore Albani, Eva C. Koffeman, Berent Prakken, Induction of immune tolerance in the treatment of rheumatoid arthritis, Nature Reviews Rheumatology, 2011, 7, 5, 272

    CrossRef

  2. 2
    Berent Prakken, Salvatore Albani, Alberto Martini, Juvenile idiopathic arthritis, The Lancet, 2011, 377, 9783, 2138

    CrossRef

  3. 3
    Daniel F. Hoft, Vladimir Brusic, Isaac G. Sakala, Optimizing vaccine development, Cellular Microbiology, 2011, 13, 7
    Direct Link:
  4. 4
    Berent J. Prakken, Salvatore Albani, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  5. 5
    Daniel H. Zimmerman, Patricia Taylor, Alison Bendele, Roy Carambula, Yvonne Duzant, Valeria Lowe, Sean P. O'Neill, Eyal Talor, Kenneth S. Rosenthal, CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model, International Immunopharmacology, 2010, 10, 4, 412

    CrossRef

  6. 6
    Stefan Tukaj, Agnieszka Kotlarz, Agnieszka Jozwik, Zaneta Smolenska, Ewa Bryl, Jacek M. Witkowski, Barbara Lipinska, Hsp40 proteins modulate humoral and cellular immune response in rheumatoid arthritis patients, Cell Stress and Chaperones, 2010, 15, 5, 555

    CrossRef

  7. 7
    E. J. Wehrens, F. van Wijk, S. T. Roord, S. Albani, B. J. Prakken, Treating arthritis by immunomodulation: is there a role for regulatory T cells?, Rheumatology, 2010, 49, 9, 1632

    CrossRef

  8. 8
    Faye A.H. Cooles, John D. Isaacs, Treating to re-establish tolerance in inflammatory arthritis – lessons from other diseases, Best Practice & Research Clinical Rheumatology, 2010, 24, 4, 497

    CrossRef

  9. 9
    Eva C. Koffeman, Mark Genovese, Diane Amox, Elissa Keogh, Ernesto Santana, Eric L. Matteson, Arthur Kavanaugh, Jerry A. Molitor, Michael H. Schiff, James O. Posever, Joan M. Bathon, Alan J. Kivitz, Rodrigo Samodal, Francis Belardi, Carolyn Dennehey, Theo van den Broek, Femke van Wijk, Xiao Zhang, Peter Zieseniss, Tho Le, Berent A. Prakken, Gary C. Cutter, Salvatore Albani, Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial, Arthritis & Rheumatism, 2009, 60, 11
    Direct Link:
  10. 10
    Lotte Wieten, Ruurd Zee, Renske Goedemans, Jeroen Sijtsma, Mauro Serafini, Nicolette H. Lubsen, Willem Eden, Femke Broere, Hsp70 expression and induction as a readout for detection of immune modulatory components in food, Cell Stress and Chaperones, 2009, 15, 1, 25

    CrossRef

  11. 11
    Ida Posiadała, Aleksander Matyl, Tomasz Szczepański, Limfocyty regulatorowe – rola fizjologiczna oraz udział w patologii wieku dziecięcego (część II), Pediatria Polska, 2009, 84, 6, 579

    CrossRef

  12. 12
    Claudia Macaubas, Khoa Nguyen, Diana Milojevic, Jane L. Park, Elizabeth D. Mellins, Oligoarticular and polyarticular JIA: epidemiology and pathogenesis, Nature Reviews Rheumatology, 2009, 5, 11, 616

    CrossRef

  13. 13
    Huib de Jong, Floris F. P. Lafeber, Wilco de Jager, Margje H. Haverkamp, Wietse Kuis, Johannes W. J. Bijlsma, Berent J. Prakken, Salvatore Albani, PAN–DR-Binding Hsp60 self epitopes induce an interleukin-10–mediated immune response in rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 7
    Direct Link:
  14. 14
    Berent J. Prakken, Salvatore Albani, Using biology of disease to understand and guide therapy of JIA, Best Practice & Research Clinical Rheumatology, 2009, 23, 5, 599

    CrossRef

  15. 15
    Rolando Cimaz, Anne Marie Prieur, Advances in pediatric rheumatology, Future Rheumatology, 2008, 3, 3, 239

    CrossRef

  16. 16
    Thomas E Ichim, Xiufen Zheng, Motohiko Suzuki, Norihiko Kubo, Xusheng Zhang, Lisa R Min, Marianne E Beduhn, Neil H Riordan, Robert D Inman, Wei-Ping Min, Antigen-specific therapy of rheumatoid arthritis, Expert Opinion on Biological Therapy, 2008, 8, 2, 191

    CrossRef

  17. 17
    Nicolas Delaleu, Ana Carina Madureira, Heike Immervoll, Roland Jonsson, Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437–460, Arthritis & Rheumatism, 2008, 58, 8
    Direct Link:
  18. 18
    Kamal D. Moudgil, Malarvizhi Durai, Regulation of autoimmune arthritis by self–heat-shock proteins, Trends in Immunology, 2008, 29, 9, 412

    CrossRef

  19. 19
    J. D. Isaacs, Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future, Rheumatology, 2008, 47, 10, 1461

    CrossRef

View Full Article (HTML) Get PDF (217K)